Redpoint Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-19,432
Closed -$3.44M 601
2020
Q1
$3.44M Hold
19,432
0.22% 115
2019
Q4
$3.71M Sell
19,432
-172
-0.9% -$31K 0.18% 138
2019
Q3
$3.3M Buy
19,604
+224
+1% +$36.5K 0.17% 150
2019
Q2
$3.25M Sell
19,380
-1,495
-7% -$207K 0.17% 149
2019
Q1
$3.06M Buy
20,875
+357
+2% +$51.8K 0.15% 172
2018
Q4
$2.74M Buy
20,518
+9,642
+89% +$1.58M 0.16% 171
2018
Q3
$2.07M Hold
10,876
0.1% 236
2018
Q2
$1.81M Sell
10,876
-11,521
-51% -$1.85M 0.1% 253
2018
Q1
$3.77M Sell
22,397
-757
-3% -$127K 0.21% 134
2017
Q4
$3.79M Buy
+23,154
New +$4.15M 0.21% 131

Other funds holding AGN

Redpoint Investment Management's AGN Position: Q2 2020 in Review

Redpoint Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 19,432 shares — an estimated $3.44M sold.

Redpoint Investment Management first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $3.79M in Q4 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Redpoint Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Redpoint Investment Management sold 19,432 Allergan plc shares in Q2 2020, an estimated $3.44M.
  • Redpoint Investment Management first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Redpoint Investment Management's Allergan plc position peaked at $3.79M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Redpoint Investment Management's 13F filing for Q2 2020, filed 17 Jul 2020.